8
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Embed Size (px)

Citation preview

Page 1: Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Enrollment and Outcomes

Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Page 2: Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Baseline Characteristics of the Patients with Chronic Kidney Disease*

Fan

Fan H

ou,

et

al. N

En

gl J M

ed

2006;3

54:1

31-4

0

Page 3: Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Kaplan-Meier Estimates of the Percentage of Patients Not Reaching the Primary Composite End Point of a Doubling of the Serum Creatinine Level,

End-Stage Renal Disease, or Death

Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Page 4: Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Use of Conventional Antihypertensive Medications at Baseline and during Study Treatment*

Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Page 5: Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Changes in Blood Pressure during Follow-up

Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Page 6: Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Changes in the Level of Proteinuria during Follow-up

Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Page 7: Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Changes in Creatinine Clearance during Follow-up

Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Page 8: Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40

Adverse Events after Randomization*

Fan Fan Hou, et al. N Engl J Med 2006;354:131-40